Skip to main content
Maternal-Fetal Medicine logoLink to Maternal-Fetal Medicine
. 2024 Jan 22;6(1):1–4. doi: 10.1097/FM9.0000000000000212

Promoting Healthy Longevity Should Start Young: A Life Course Journey

Cuilin Zhang 1,2,3,4,, Claire Guivarch 1,2,3
Editor: Yang Pan
PMCID: PMC12106190  PMID: 40433312

Introduction

Throughout a woman’s life, several unique health characteristics are related to an increased risk of later disease morbidity and/or premature mortality (Fig. 1). For instance, these include early age at menarche1,2 (ie, “short, irregular or long menstrual cycles”),3,4 a history of infertility,5 pregnancy loss,6 several major pregnancy complications (eg, preeclampsia, gestational hypertension, gestational diabetes mellitus (GDM) and preterm delivery),79 and menopause characteristics (eg, long menopause transition period, early age at menopause, and the presence of vasomotor symptoms).10,11 Additionally, accumulating evidence supports the intergenerational impacts of maternal health and well-being on child health.12 Taken together, these associations imply that achieving healthy longevity is a lifelong journey. The promotion of healthy longevity should start at a young age and not deferred until later in life, to enhance the health and life quality of both women and their offspring. In this perspective article, we aim to discuss the relevance of reproductive health and pregnancy outcomes for promoting healthy longevity for young, middle-aged, and future elderly women, as well as the next generations, based on results from large human epidemiological studies.

Figure 1.

Figure 1

Reproductive and obstetric health status of women and its association with long-term morbidities and mortality. BMI: Body Mass Index.

Menstrual health and morbidities/premature mortality

Menstrual health characteristics, such as the regularity and length of menstrual cycles, have been regarded as an indicator of the overall health of reproductive-age women. For instance, both irregular and long menstrual cycles have been related to increased rates of cardiovascular diseases3 and premature mortality.13 Notably, women who had irregular, frequent, or infrequent menstrual cycles were at a higher risk of several cardiometabolic diseases, including type 2 diabetes, compared to women with a regular menstrual cycle or a normal cycle frequency, as indicated by a retrospective matched cohort study involving over 700,000 women from the United Kingdom.3 Moreover, women with usually irregular or always irregular menstrual cycles were found to have a greater risk of premature mortality starting from 50 years old.13 All these associations were observed after the adjustment for major confounders, such as women's body adiposity status. These findings suggest that menstrual cycle characteristics might serve as a proxy for the overall health status of reproductive-age women and may help identify high-risk women in early and middle-aged adulthood.

Pregnancy complications and premature mortality

Pregnancy is a critical event in parous women's lives that could have substantial lifelong health implications. Throughout pregnancy, women's body experiences tremendous cardiometabolic and hormonal changes. These changes may be considered as stress tests or challenges to identify women who are at greater risk of developing cardiometabolic diseases later in their lives.14 Accumulating data from large epidemiological studies have demonstrated that pregnancy complications may help identify women at a higher risk for chronic diseases in later life. For example, women who experienced GDM were related to more than a seven-fold increased risk of developing type 2 diabetes later in life, even though their blood glucose levels often return to normal after delivery.15 Women with a history of GDM were also found to exhibit a higher risk for cardiovascular diseases, as well as renal and liver dysfunctions.1618 Similarly, women who experienced other common pregnancy complications such as preterm delivery or hypertensive disorders during pregnancy, were related to an increased risk for cardiovascular diseases in later life.19 For instance, we recently found that women who experienced preeclampsia, gestational hypertension, GDM, or preterm delivery have an increased risk of premature mortality in the next 50 years after the index pregnancy, based on the data from a US diverse cohort, which enrolled 45,000 Caucasian and African American pregnant women between the 1950s and 1960s.7 Within the same cohort, we also observed that women with gestational weight gain above the recommendations had a higher incidence of mortality from heart disease or diabetes than women who followed the recommendations.20 These findings support the importance of achieving healthy gestational weight gain within recommendations, emphasizing that the implications may extend beyond the pregnancy period to long-term health, including cardiovascular mortality.

Intergenerational impacts of women's health and links to premature mortality

The health status of reproductive-age women is important not only for their own later health but also for the health of their offspring. The first 1,000 days of life (from conception to the 2 years of the child) has been regarded as a critical period for short- and long-term health.12 Using gestational diabetes as an example, the “diabetes begetting diabetes vicious circle” is well-known. Offspring born from pregnancies complicated by GDM are at high risk for developing cardiometabolic disorders, such as obesity and impaired glucose tolerance. When these individuals become pregnant, they are more likely to develop GDM themselves, thereby creating a vicious circle that may impact multiple generations.21 Birth weight, a proxy of in-uterine growth measurement, has been repeatedly related to morbidities, such as type 2 diabetes and cardiovascular diseases in multiple studies and recently with premature mortality.

In summary, emerging and accumulating evidence supports links between major women's reproductive health events with later disease risk and premature mortality. These results can help to identify women at high risk for targeted intervention for improving healthy longevity.

Healthy diet and lifestyle promotion are promising for improving women's health and longevity

Identifying these high-risk populations is the first step to promoting healthy longevity. The next critical step is to highlight factors that could be helpful to improve the health and longevity among these high-risk women, as such to lower morbidities and premature mortality.

In that context, several studies have shown that a healthy diet and adequate lifestyle can lower the risk of adverse reproductive and pregnancy complications, as well as the risks of chronic diseases among high-risk women, and therefore increase their life expectancy. For instance, a previous study highlighted that three commonly recommended healthy dietary patterns (ie, Mediterranean diet, Healthy Eating Index based on current US dietary guidance, and the DASH diet (Dietary Approaches to Stop Hypertension)) in early pregnancy and midpregnancy were related to reduced risks of major pregnancy complications, such as preterm delivery, preeclampsia, gestational hypertension, and GDM.22 We also previously found that 46% of GDM cases may be prevented by adopting four factors: healthy diet, regular exercise, normal BMI, and not smoking.23 In another study, based on more than 4,000 GDM cases followed up for more than 30 years, we observed that adopting a healthy diet and lifestyle is related to a 92% lower risk for T2D among women with a history of GDM.24 Moreover, a recent meta-analysis concluded that changing a Western diet to an optimal diet could increase life expectancy by more than 10 years.25 Authors concluded that the largest gains would be made by eating more legumes, whole grains, and nuts, and less red meat. They also emphasized that the earlier the dietary changes are initiated in life, the larger the gain in life expectancy.

Discussion

In this perspective article, we have discussed compelling evidence supporting the notion that promoting longevity should start young, with keen attention to women's health during their reproductive years. All the studies presented are based on large human populations. In contrast to animal studies or randomized controlled trials, population studies cannot establish causality. Nevertheless, the presented evidence from high-quality human population data, at least, highlights the significance of reproductive health events occurring early or in midlife for women across their lifespan and generations.

Future direction

Future research should pursue the assessment of risk factors and biomarkers to enable the early identification of high-risk women and then to follow up these women, intervene, and prevent complications. Diet and lifestyle modifications have been demonstrated effective in research studies; however, achieving sustainable behavior modifications remains challenging. Future endeavors for developing and implementing sustainable healthy diets and lifestyle modifications at a population level shall involve multidisciplinary efforts and the participation of political decision-makers. In addition, it should be pointed out that studies on long-term health implications of reproductive and obstetric complications among the Asian population are emerging but still very limited.26,27 Indeed, even though Asians represent more than 60% of the world's population, only 10% of clinical trials and genetic databases have Asian representation. This underrepresentation could lead to important disparities in health outcomes for the Asian population and should, therefore, be addressed in future studies.

Conclusion

To conclude, the results of large human epidemiological studies emphasize the long-term impacts of women's reproductive health events on their later health and the health of their offspring, highlighting the importance of considering these early characteristics to promote healthy longevity. Future research should pursue the assessment of factors and biomarkers to identify women at high risk early in life and to support their behavior change, notably among the Asian population.

Funding

None.

Author Contributions

Cuilin Zhang conceptualized, contributed to the discussion, drafted and edited the manuscript, and supervised the paper. Claire Guivarch drafted the manuscript and contributed to the discussion. Both authors reviewed and approved the final version of the paper, and contributed to the design and the content of the figure.

Editor Note

Cuilin Zhang is the Editor-in-Chief of Maternal-Fetal Medicine. The article was subject to the journal's standard procedures, with peer review handled independently of this editor and the associated group.

Footnotes

How to cite this article: Zhang C, Guivarch C. Promoting Healthy Longevity Should Start Young: A Life Course Journey. Maternal Fetal Med 2024;6(1):1–4. doi: 10.1097/FM9.0000000000000212.

Contributor Information

Claire Guivarch, Email: guivarch@nus.edu.sg.

Yang Pan, Email: 269330035@qq.com.

Conflicts of Interest

None.

References

  • 1.Charalampopoulos D McLoughlin A Elks CE, et al. Age at menarche and risks of all-cause and cardiovascular death: a systematic review and meta-analysis. Am J Epidemiol 2014;180(1):29–40. doi: 10.1093/aje/kwu113. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 2.He C Zhang C Hunter DJ, et al. Age at menarche and risk of type 2 diabetes: results from 2 large prospective cohort studies. Am J Epidemiol 2010;171(3):334–344. doi: 10.1093/aje/kwp372. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 3.Okoth K Smith WP Thomas GN, et al. The association between menstrual cycle characteristics and cardiometabolic outcomes in later life: a retrospective matched cohort study of 704,743 women from the UK. BMC Med 2023;21(1):104. doi: 10.1186/s12916-023-02794-x. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 4.Huang C Lin B Yuan Y, et al. Associations of menstrual cycle regularity and length with cardiovascular diseases: a prospective study from UK Biobank. J Am Heart Assoc 2023;12(11):e029020. doi: 10.1161/JAHA.122.029020. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 5.Tobias DK Gaskins AJ Missmer SA, et al. History of infertility and risk of type 2 diabetes mellitus: a prospective cohort study. Diabetologia 2015;58(4):707–715. doi: 10.1007/s00125-015-3493-z. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 6.Kharazmi E Dossus L Rohrmann S, et al. Pregnancy loss and risk of cardiovascular disease: a prospective population-based cohort study (EPIC-Heidelberg). Heart 2011;97(1):49–54. doi: 10.1136/hrt.2010.202226. [DOI] [PubMed] [Google Scholar]
  • 7.Hinkle SN Schisterman EF Liu D, et al. Pregnancy complications and long-term mortality in a diverse cohort. Circulation 2023;147(13):1014–1025. doi: 10.1161/circulationaha.122.062177. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 8.Wang YX Arvizu M Rich-Edwards JW, et al. Hypertensive disorders of pregnancy and subsequent risk of premature mortality. J Am Coll Cardiol 2021;77(10):1302–1312. doi: 10.1016/j.jacc.2021.01.018. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 9.Täufer Cederlöf E Lundgren M Lindahl B, et al. Pregnancy complications and risk of cardiovascular disease later in life: a nationwide cohort study. J Am Heart Assoc 2022;11(2):e023079. doi: 10.1161/JAHA.121.023079. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 10.El Khoudary SR. Age at menopause onset and risk of cardiovascular disease around the world. Maturitas 2020;141:33–38. doi: 10.1016/j.maturitas.2020.06.007. [DOI] [PubMed] [Google Scholar]
  • 11.El Khoudary SR Aggarwal B Beckie TM, et al. Menopause transition and cardiovascular disease risk: implications for timing of early prevention: a scientific statement from the American Heart Association. Circulation 2020;142(25):e506–e532. doi: 10.1161/CIR.0000000000000912. [DOI] [PubMed] [Google Scholar]
  • 12.Gluckman PD, Buklijas T, Hanson MA. . Elsevier; 2016:1–5. doi: 10.1016/B978-0-12-801383-0.00001-3. [DOI] [Google Scholar]
  • 13.Wang YX Arvizu M Rich-Edwards JW, et al. Menstrual cycle regularity and length across the reproductive lifespan and risk of premature mortality: prospective cohort study. BMJ 2020;371:m3464. doi: 10.1136/bmj.m3464. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 14.Sattar N, Greer IA. Pregnancy complications and maternal cardiovascular risk: opportunities for intervention and screening? BMJ 2002;325(7356):157–160. doi: 10.1136/bmj.325.7356.157. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 15.Bellamy L Casas JP Hingorani AD, et al. Type 2 diabetes mellitus after gestational diabetes: a systematic review and meta-analysis. Lancet 2009;373(9677):1773–1779. doi: 10.1016/S0140-6736(09)60731-5. [DOI] [PubMed] [Google Scholar]
  • 16.Rawal S Olsen SF Grunnet LG, et al. Gestational diabetes mellitus and renal function: a prospective study with 9- to 16-year follow-up after pregnancy. Diabetes Care 2018;41(7):1378–1384. doi: 10.2337/dc17-2629. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 17.Tobias DK Stuart JJ Li S, et al. Association of history of gestational diabetes with long-term cardiovascular disease risk in a large prospective cohort of US women. JAMA Intern Med 2017;177(12):1735–1742. doi: 10.1001/jamainternmed.2017.2790. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 18.Li S Zhu Y Chavarro JE, et al. Healthful dietary patterns and the risk of hypertension among women with a history of gestational diabetes mellitus: a prospective cohort study. Hypertension 2016;67(6):1157–1165. doi: 10.1161/hypertensionaha.115.06747. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 19.Parikh NI Gonzalez JM Anderson CAM, et al. Adverse pregnancy outcomes and cardiovascular disease risk: unique opportunities for cardiovascular disease prevention in women: a scientific statement from the American Heart Association. Circulation 2021;143(18):e902–e916. doi: 10.1161/CIR.0000000000000961. [DOI] [PubMed] [Google Scholar]
  • 20.Hinkle SN Mumford SL Grantz KL, et al. Gestational weight change in a diverse pregnancy cohort and mortality over 50 years: a prospective observational cohort study. Lancet 2023;402(10415):1857–1865. doi: 10.1016/S0140-6736(23)01517-9. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 21.McIntyre HD Catalano P Zhang C, et al. Gestational diabetes mellitus. Nat Rev Dis Primers 2019;5(1):47. doi: 10.1038/s41572-019-0098-8. [DOI] [PubMed] [Google Scholar]
  • 22.Li M Grewal J Hinkle SN, et al. Healthy dietary patterns and common pregnancy complications: a prospective and longitudinal study. Am J Clin Nutr 2021;114(3):1229–1237. doi: 10.1093/ajcn/nqab145. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 23.Zhang C Tobias DK Chavarro JE, et al. Adherence to healthy lifestyle and risk of gestational diabetes mellitus: prospective cohort study. BMJ 2014;349:g5450. doi: 10.1136/bmj.g5450. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 24.Yang J Qian F Chavarro JE, et al. Modifiable risk factors and long term risk of type 2 diabetes among individuals with a history of gestational diabetes mellitus: prospective cohort study. BMJ 2022;378:e070312. doi: 10.1136/bmj-2022-070312. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 25.Fadnes LT Økland JM Haaland ØA, et al. Estimating impact of food choices on life expectancy: a modeling study. PLoS Med 2022;19(2):e1003889. doi: 10.1371/journal.pmed.1003889. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 26.Nguyen HT Zheng A Gugel A, et al. Asians and Asian subgroups are underrepresented in medical research studies published in high-impact generalist journals. J Immigr Minor Health 2021;23(3):646–649. doi: 10.1007/s10903-021-01142-6. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 27.Azzopardi R Nicholls SJ Nerlekar N, et al. Asia-Pacific Investigators and Asian Enrollment in Cardiometabolic Trials: insights from publications between 2011 and 2020 [published online July 4, 2023]. JACC Asia . doi: 10.1016/j.jacasi.2023.05.010. [DOI] [PMC free article] [PubMed] [Google Scholar]

Articles from Maternal-Fetal Medicine are provided here courtesy of Wolters Kluwer Health

RESOURCES